Advertise with us
Subscribe
Subscribe to World Briefings's newsletter

News Updates

Let's join our newsletter!

Do not worry we don't spam!

ESMO

Explore All ESMO News and Updates Here
Jazz Pharmaceuticals Reports Encouraging 30-Month Survival Data for Zanidatamab in Gastric Cancer

World

17 Sep, 2024
Maria Garcia

Jazz Pharmaceuticals Reports Encouraging 30-Month Survival Data for Zanidatamab in Gastric Cancer

Jazz Pharmaceuticals has posted fresh phase 2 data on zanidatamab that show the HER2-targeted bispecific antibody kept 59% of people...

Lung Cancer Drug Shows Promise: TIGIT-Targeting Antibody + Jemperli Combo Shows Significant Tumor Shrinkage

World

16 Sep, 2024
Kwame Osei

Lung Cancer Drug Shows Promise: TIGIT-Targeting Antibody + Jemperli Combo Shows Significant Tumor Shrinkage

A targeted immunotherapy being developed by the biotech iTeos Therapeutics and GSK delivered promising response rates in patients with a...

News Categories
Follow Us
Newsletter
Subscribe to Newsletter

Stay Tuned With Updates